Frailty and comorbidity are among the most problematic expressions of advancing age. Frailty is defined as a state of increased vulnerability to disease resulting from a progressive physiological decline in the functional reserve of multiple organs and systems. The concept of frailty is distinct from, yet closely related to, that of comorbidity, defined as the coexistence of two or more diseases in the same individual. Older patients with heart failure, many of whom are frail and affected by multiple concomitant disorders requiring complex medication regimens, are at very high risk for adverse outcomes and, therefore, have the greatest need of assistance and care. Disappointingly, frail older adults with comorbidity and polypharmacy have be...
Prevalence of heart failure is increasing, especially in the elderly population. Noncardiac comorbid...
This feature article for the thematic series on congestive heart failure (CHF) readmissions aims to ...
Non-cardiac comorbidity complicates heart failure care and is prevalent in one form or another for t...
This author manuscript is made available in accordance with the publisher's Self-Archiving policy T...
Abstract People over 65 years of age constitute over 80% of patients with heart failure (HF) and the...
Frailty is a multisystemic process leading to reduction of physiological reserve and a reduction in ...
Advanced age is a relevant risk factor for the heart failure (HF). The development of new pharmacolo...
Frailty is a multisystemic process leading to reduction of physiological reserve and a reduction in ...
Abstract Aims The heart failure (HF) prognosis in older patients remains poor with a high 5‐years mo...
International audienceAIMS: The heart failure (HF) prognosis in older patients remains poor with a h...
There are over 5 million Americans with heart failure (HF), the majority of whom are over age 65. Fr...
Introduction. Heart failure (HF) is a clinical syndrome consisting of cardinal symptoms accompanied ...
Heart failure (HF) is difficult to diagnose and treat in older patients. Symptoms may be non-specifi...
Prevalence of heart failure is increasing, especially in the elderly population. Noncardiac comorbid...
This feature article for the thematic series on congestive heart failure (CHF) readmissions aims to ...
Non-cardiac comorbidity complicates heart failure care and is prevalent in one form or another for t...
This author manuscript is made available in accordance with the publisher's Self-Archiving policy T...
Abstract People over 65 years of age constitute over 80% of patients with heart failure (HF) and the...
Frailty is a multisystemic process leading to reduction of physiological reserve and a reduction in ...
Advanced age is a relevant risk factor for the heart failure (HF). The development of new pharmacolo...
Frailty is a multisystemic process leading to reduction of physiological reserve and a reduction in ...
Abstract Aims The heart failure (HF) prognosis in older patients remains poor with a high 5‐years mo...
International audienceAIMS: The heart failure (HF) prognosis in older patients remains poor with a h...
There are over 5 million Americans with heart failure (HF), the majority of whom are over age 65. Fr...
Introduction. Heart failure (HF) is a clinical syndrome consisting of cardinal symptoms accompanied ...
Heart failure (HF) is difficult to diagnose and treat in older patients. Symptoms may be non-specifi...
Prevalence of heart failure is increasing, especially in the elderly population. Noncardiac comorbid...
This feature article for the thematic series on congestive heart failure (CHF) readmissions aims to ...
Non-cardiac comorbidity complicates heart failure care and is prevalent in one form or another for t...